Ambroxol hydrochloride (AM) [trans-4-(2-amino-3,5-dibromobenzylamino) cyclohexanol Hydrochloride] 1 is semi-synthetic derivative of vasicine obtained from Indian shrub Adhatoda vasica. It is a metabolic product of bromhexine. It is used as broncho secretolytic and expectorant drug 2 . It stimulates the transportation of the viscous secretions in the respiratory organs and reduces the stand stillness of the secretions. Several spectrophotometric methods have been reported for the qualitative and quantitative determination of AM from pharmaceutical formulations [3] [4] [5] [6] . GLC 11, 12 , LC-MS 13 and Capillary electrophoretic 14 methods are also reported for it's determination from biological fluids. Cetirizine hydrocloride (CE) [2-[4-(4-chlorobenzhydryl) piperazine-1-yl]ethoxyacetic acid] is the carboxylated metabolite of hydroxyzine and having high specifi c affi nity for histamine H 1 receptor. It is second generation antihistaminic drug. Literature survey revels that several spectrophotometric [15] [16] [17] [18] methods, HPLC methods [19] [20] [21] [22] , HPLC coupled to tandem mass spectroscopy 23 , capillary electrophoretic 24-25 have been also reported for determination of CE from pharmaceutical formulations and biological fl uids.
Ambroxol hydrochloride (AM) [trans-4-(2-amino-3,5-dibromobenzylamino) cyclohexanol Hydrochloride] 1 is semi-synthetic derivative of vasicine obtained from Indian shrub Adhatoda vasica. It is a metabolic product of bromhexine. It is used as broncho secretolytic and expectorant drug 2 . It stimulates the transportation of the viscous secretions in the respiratory organs and reduces the stand stillness of the secretions. Several spectrophotometric methods have been reported for the qualitative and quantitative determination of AM from pharmaceutical formulations [3] [4] [5] [6] . Various HPLC [7] [8] [9] [10] , GLC 11, 12 , LC-MS 13 and Capillary electrophoretic 14 methods are also reported for it's determination from biological fluids. Cetirizine hydrocloride (CE) [2-[4-(4-chlorobenzhydryl) piperazine-1-yl]ethoxyacetic acid] is the carboxylated metabolite of hydroxyzine and having high specifi c affi nity for histamine H 1 receptor. It is second generation antihistaminic drug. Literature survey revels that several spectrophotometric [15] [16] [17] [18] methods, HPLC methods [19] [20] [21] [22] , HPLC coupled to tandem mass spectroscopy 23 , capillary electrophoretic [24] [25] have been also reported for determination of CE from pharmaceutical formulations and biological fl uids.
The present research work describes rapid, accurate, sensitive and reproducible RP-HPLC method and absorbance ratio method for simultaneous determination of AM and CE from the tablet formulation.
MATERIALS AND METHODS
AM was procured from Litaka Pharmaceuticals, Pune (India) and CE was kindly supplied as gift sample by Mediorals, Satara (India). Hydrochlorothiazide (HT) was supplied by (IPCA) Pharmaceuticals (India). All the reagents used were of analytical reagent grade. A commercial preparation (Relent tablets, Dr. Reddy's laboratories, India, Batch No: 2073) used for analysis was procured from the local pharmacy. Each film coated tablet contains 60 mg of AM and 5 mg of CE.
HPLC method (method I):
HPLC Model-Jasco PU-2080 equipped with UV/Vis detector (Jasco UV-2075 plus), Column dimensions, HIQ SIL-C 18 -column (250×4.6 mm i.d., 10 μm particle size)) Kya Tech, Japan with an isocratic mode was used at a fl ow rate of 1.0 ml/min at room temperature with injection volume of 20 μl and wavelength detection at 229 nm). The mobile phase used for RP-HPLC was methanol-acetonitrile-water (40:40:20, v/v/v).
Preparation of standard stock solutions:
Standard stock solution containing AM and CE was prepared by dissolving 50 mg of AM and 5 mg CE in 40 ml of methanol. It was then sonicated for 10 min and then fi nal volume of the solution was made up to 50 ml with methanol to get stock solution containing 1000 μg/ml of AM and 100 μg/ml of CE in 50 ml volumetric fl ask. Standard stock solution of HT was prepared by dissolving 5 mg of HT in 40 ml of methanol and then sonicated for 10 min. The fi nal volume of solution was made up to 50 ml with methanol to get 100 μg/ml of HT.
Linearity study:
In to a series of 10 ml volumetric fl asks, 1.2 to 4.8 ml of AM and 1 to 3.5 ml of CE solution were pipetted and to each fl ask 0.2 ml of HT was added and then fi nal volume of the solutions was made up to 10 ml with methanol. A 20 μl of sample solution was injected into the injection port of chromatographic system having fixed volume loop injector. Chromatograms were noted and response factor was plotted against concentration to get calibration curve. Chromatogram of physical mixture of AM and CE is shown in fi g. 1. Overlain chromatogram of physical mixture is shown in fi g. 2. The regression equation data for the calibration curve is represented in Table 1 for AM and CE.
Sample preparation:
From the triturate of 20 tablets, an amount equivalent to 30 mg of AM and 2.5 mg of CE was weighed and dissolved in 40 ml of methanol by sonicating for 10 min. The solution was fi ltered through 0.22 μ membrane fi lter and then fi nal volume of the solution was made up to 100 ml with methanol to get stock solution containing 300 μg/ml of AM and 25 μg/ml of CE in 100 ml volumetric fl ask. After appropriate dilutions, the solutions were run on HPLC system and the concentration of each analyte was determined with the equations generated. The statistical data obtained after replicate determinations is shown in Table 2 .
Absorbance ratio method (Method II)
A PC based Jasco V-530 recording spectrophotometer with spectral bandwidth of 2 nm and wavelength accuracy±0.5 nm (with automatic wavelength correction) was employed for all measurements using a matched pair of 10 mm quartz cell. Shimadzu AY 120 analytical balance was used for weighing. Methanol HPLC grade was purchased from Merck Pharmaceuticals (India). Glass distilled water was prepared in the laboratory.
Preparation of standard stock solution:
Standard stock solution containing AM and CE was prepared by dissolving 10 mg of AM and CE separately in 20 ml of methanol and then fi nal volume of both the solutions was made up to 100 ml with glass distilled water to get stock solution containing 100 μg/ml of each AM and CE in two different 100 ml volumetric fl asks.
Determination of absorptivity:
By appropriate dilution of standard drug solutions with .
Preparation of mixed standard solutions:
Each marketed tablet formulation of the two drug contains AM 60 mg and CE 5 mg. The standard stock solution of AM and CE was used to prepare seven mixed standards containing 30-48 μg/ml of AM and 7.5-12 μg/ml of CE.
Framing Equations:
From the molar absorptivity values determined for AM and CE the simultaneous equation is derived for determination of AM and CE in pure drug mixed standards and in its pharmaceutical formulation. The equations framed are
, where C 1 is concentration of AM in g dm -3 , C 2 is concentration of CE in g dm -3 , a 1 is absorptivity of AM at 236 nm, a 2 is absorptivity of CE at 236 nm, Q 0 is ratio of absorbance of sample at 243 nm and 236 nm, Q 1 is ratio of absorptivity of AM at 243 nm and 236 nm, Q 2 is ratio of absorptivity of CE at 243 nm and 236 nm and A is absorbance of sample at isoabsorptive point.
Sample preparation:
Marketed tablet formulations containing 60 mg of AM and 5 mg of CE were analyzed by this method. From the triturate of 20 tablets, an amount equivalent to 30 mg of AM and 2.5 mg of CE was weighed and transferred to 100 ml volumetric fl ask. A 5 mg of pure CE was added to the volumetric fl ask. The contents of the fl ask were dissolved in the 60 ml of the solvent with the aid of ultrasonication for 10 min. The solution was filtered through whatmann filter paper no. 41 and then final volume of the solution was made up to 100 ml with glass double distilled water to get a stock solution containing 300 μg/ml of AM and 75 μg/ml of CE. After appropriate dilutions, the absorbances were measured and the concentration of each analyte was determined with the equations generated. The statistical data obtained after replicate determinations (n = 9) is shown in Table 2 .
RESULTS AND DISCUSSION
The primary target in developing this liquid chromatographic method was to achieve simultaneous estimation of AM and CE in the pharmaceutical formulation under common conditions that are applicable for routine quality control of this product in laboratories. In RP-HPLC method, mobile phase containing of a mixture of methanol-acetonitrile-water (40:40:20) was selected which produces satisfactory resolution, reasonable retention and acceptable peak shape for both the drugs. The optimization of wavelength was done at different wavelengths for detection by UV detector. In the present investigation, drug solutions of 10 μg/ml of AM and 10 μg/ml of CE were prepared in methanol. AM and CE showed wavelength maxima at 243 nm and 229 nm, respectively. After observing UV spectra of both the drugs, wavelength of 229 nm was selected for further study. Keeping in view the physicochemical properties of both the drugs in the formulation, few drug molecules were tested for use as an internal standard with respect to resolution suitability. HT was found to give good resolution and accurate and precise quantitative results. A fl ow rate of 1 ml/min resulted in optimum retention times with good resolution and with all the drug components and internal standards eluting within 15 min.
The tablet matrix was also estimated to check interference if any, from the excipients used in the tablet matrix. No signifi cant peaks from tablet matrix were observed in the developed chromatograms indicated there is no interference from the excipients of the tablet matrix. The retention time is 2.792 min for HT, 4.155 min for CE and 10.495 min for AM, respectively. The run time is less than 15 min.
In absorbance ratio method, methanol: water (1:4) was selected as common solvent. Drug solutions of concentration 10 μg/ml of AM and CE separately were prepared by appropriate dilution of stock solutions. These drug solutions were scanned in the range of 200 to 350 nm to determine wavelength of maximum absorption and isoabsorptive point. AM shows characteristic peaks at 207, 243 and 306 nm while absorbance maxima for CE is 229 nm, respectively. The isoabsorptive point was obtained at 236 nm. The wavelengths selected were 243 nm (λ max of AM) and 236 nm (isoabsorptive point). The overlain spectra of AM and CE is shown in fi g. 3.
The linearity of responses of the method I for both drugs was verified at six concentration levels 120 to 480 μg/ml for AM and 10-35 μg/ml for CE, respectively. The calibration curve was constructed by plotting response against concentration of the drug. The results showed that an excellent correlation existed between peak area and concentration of each drug within the concentration range tested by this method. The quantitation limit of an individual analyte is the lowest concentration of analyte in a sample, which can be established at a signal to noise ratio of 10. The LOQ of AM and CE was found to be 0.1076 and 0.2160 μg/ml, respectively. The detection limit of an individual analyte is the lowest amount of analyte in a sample, which can be detected but not necessarily quantitated as an exact value. The LOD of AM and CE was found to be 0.0328 and 0.0648 μg/ml, respectively. The data for LOD and LOQ is given in Table 1 .
Accuracy was determined by applying developed method to synthetic mixtures of excipients to which known amounts of each drug corresponding to 50, 100 and 150 percent of label claim had been added. Table 3 .
The linearity of responses of the method II for both the drugs was verified by preparing different concentration levels 1 to 50 μg/ml and 2 to 80 μg/ ml for AM and CE, respectively. Beer's law was obeyed in the concentration range of 5 to 50 μg/ml and 7.5 to 75 μg/ml for AM and CE, respectively. The LOQ of AM and CE were found to be 3.75 and 1.45 μg/ml, respectively. The LOD of AM and CE was found to be 1.12 and 0.45 μg/ml, respectively. The data for LOD and LOQ is given in Table 1 .
The accuracy was calculated as the percentage of analyte recovered from the tablet matrix. Mean recoveries (mean percentage±standard deviation) values were 99.82±0.62 and 100.35±1.26 for AM and CE, respectively. Results of recovery study are close to the 100 percentage indicating non-interference of common excipients used in the tablet formulation. The data for recovery studies and precision is given in Tables 3 and 4 , respectively.
The results of analysis of methods developed were compared with the reported HPTLC method by performing two way anova studies. Anova studies were performed by using software Graphpad Prism 5.0. F test value at confidence interval 99% was found to be less than Table 5 .
AM and CE was simultaneously determined in tablet matrix using two different analytical methods. The methods developed are simple, accurate, rapid, sensitive and specifi c. RP-HPLC and absorbance ratio spectrophotometry may be recommended for routine and quality control analysis of investigated drugs in two component pharmaceutical preparations.
